A-Z Index
Image Cart
              

 Information For:

Manufacturers

Regulator

Healthcare

Consumers

Members


Errata to <467> Organic Volatile Impurities Section in USP Monographs revised in Supplement 1

October 15, 2007

During the production process of the electronic version of Supplement 1 to USP 30–NF 25, while the "Official until" date of Organic Volatile Impurities throughout the USP–NF still read "Official until July 1, 2007," the OVI section in the following monographs was erroneously deleted. Since that time, the decision was made to extend the official date of this section throughout the USP–NF by one year, until July 1, 2008.

This correction appears on all OVI sections in the coming USP 31–NF 26, and these monographs have been corrected to again include the OVI information, reflecting the "Official until July 1, 2008" date.

  1. Alfadex  (35KB)
  2. Allopurino  (19KB)
  3. Amifostine  (17KB)
  4. Atracurium Besylate  (40KB)
  5. Cholestyramine Resin  (13KB)
  6. Doxepin Hydrochloride  (24KB)
  7. Flumazenil  (23KB)
  8. Fluvoxamine Maleate  (22KB)
  9. Hydrocodone Bitartrate  (24KB)
  10. Ibuprofen  (17KB)
  11. Nefazodone  (22KB)
  12. Ondansetron  (20KB)
  13. Oxybutynin Chloride  (24KB)
  14. Paroxetine Hydrochloride  (33KB)
  15. Polyethylene Oxide  (13KB)
  16. Potassium Perchlorate  (10KB)
  17. Ritonavir  (33KB)
  18. Tomato Extract Containing Lycopene  (21KB)

What's New

Changes to the Dissolution Performance Verification Test (11/20/09)

PF 35(6) Errata (10/30/09)

New official Text for October: 15 Revisions Bulletins (10/30/09)

Pending Standards for the month of October (10/30/09)

PF 35(6), November-December 2009: Highlights and Stimuli Articles (10/23/09)

Admission Criteria and Safety Classification for Dietary Supplements Guideline (10/22/09)

Elemental Impurities Hot Topics information updated (10/13/09)

General Chapter <1151> Pharmaceutical Dosage Forms (10/06/09)

Heparin Hot Topics information updated (10/02/09)

PF Redesign

Related Resources